CN101181466B - Chinese traditional medicine for curing nephrosis - Google Patents
Chinese traditional medicine for curing nephrosis Download PDFInfo
- Publication number
- CN101181466B CN101181466B CN2007101146621A CN200710114662A CN101181466B CN 101181466 B CN101181466 B CN 101181466B CN 2007101146621 A CN2007101146621 A CN 2007101146621A CN 200710114662 A CN200710114662 A CN 200710114662A CN 101181466 B CN101181466 B CN 101181466B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese
- nephropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a nephropathy chemotherapeutic drug, in particular to a Chinese traditional medicine for treating nephropathy. The invention has the technical proposal that: the invention comprises the following raw materials making into effective components: Chinese caterpillar fungus of 15 to 25 parts, radix astragali of 20 to 30 parts, liquoric root of 5 to 12 parts, rhubarb of 5 to 12 parts, Chinese magnoliavine fruit of 8 to 12 parts, seaweed of 12 to 18 parts, rehmanniae praeparatum of 20 to 28 parts, rehmanniae vaporata of 20 to 28 parts, szechuan lovage rhizome of 5 to 12 parts, musk of 5 to 8 parts, bezoar of 5 to 12 parts, tuber fleeceflower root of 15 to 25 parts, Chinese yam rhizome of 20 to 35 parts, American ginseng of 15 to 25 parts and angelica of 15 to 25 parts. The invention has the advantages that: the Chinese traditional medicine prescription of the invention has the functions of tonifing qi-yin no affecting humidity and clearing away heat and toxic material no hurting ortho, and has obvious effect on treating nephropathy. Approved by clinic, the invention has obvious healing effect and high cure rate.
Description
One, technical field:
The present invention relates to a kind of treatment of kidney disease medicine, particularly a kind of middle medicament for the treatment of nephropathy.
Two, background technology:
Kidney is one of human body vitals, and the renal failure cause of disease is caused that by multiple factor the traditional Chinese medical science belongs to categories such as edema, asthenia, the kidney-wind syndrome; Nephropathy is a kind of disease of refractory, and the Chinese medicine patent of multiple treatment nephropathy is arranged in the Chinese patent literature, truly has certain curative effect, but still can not be satisfactory.
Three, summary of the invention:
Purpose of the present invention is exactly the above-mentioned defective that exists at prior art, and a kind of middle medicament that the treatment nephropathy of obvious curative effects is arranged is provided.
Its technical scheme is: be made up of the following raw materials of effective components of making: Cordyceps 15-25 part, Radix Astragali 20-30 part, Radix Glycyrrhizae 5-12 part, Radix Et Rhizoma Rhei 5-12 part, Fructus Schisandrae Chinensis 8-12 part, Sargassum 12-18 part, Radix Rehmanniae 20-28 part, Radix Rehmanniae Preparata 20-28 part, Rhizoma Chuanxiong 5-12 part, Moschus 5-8 part, Calculus Bovis 5-12 part, Radix Polygoni Multiflori 15-25 part, Rhizoma dioscoreae 20-35 part, Radix Panacis Quinquefolii 15-25 part and Radix Angelicae Sinensis 15-25 part.
Preferable technical scheme is made up of the following raw materials of effective components of making: 20 parts of Cordyceps, 25 parts of the Radixs Astragali, 9 parts in Radix Glycyrrhizae, 9 parts of Radix Et Rhizoma Rhei, 10 parts of Fructus Schisandrae Chinensis, 16 parts of Sargassums, 25 parts in the Radix Rehmanniae, 25 parts in Radix Rehmanniae Preparata, 20 parts of 10 parts of Rhizoma Chuanxiongs, 6 parts in Moschus, 10 parts of Calculus Boviss, 20 parts of Radix Polygoni Multiflori, 30 parts of Rhizoma dioscoreaes, 20 parts of Radix Panacis Quinquefoliis and Radix Angelicae Sinensis.
The traditional Chinese medical science is thought: chronic nephropathy relates to spleen, lung, kidney three dirty losss, with the kidney loss the most very, and damp and hot through the course of disease all the time because the life-time service hormone, often bring deficiency of both YIN and YANG, accompany damp and hot principal contradiction, and the present invention selects Cordyceps, the Radix Astragali, Radix Panacis Quinquefolii, Radix Polygoni Multiflori, Rhizoma dioscoreae, Radix Angelicae Sinensis, the Radix Rehmanniae, Radix Rehmanniae Preparata for use, gas, cloudy giving young employees remedial-courses in general knowledge and vocational skills, and negative and positive two turn round and look at, have diuretic concurrently, it is dirty to take spleen, lung, kidney three into account; Radix Glycyrrhizae, Radix Et Rhizoma Rhei heat-clearing and toxic substances removing, the clear meridians apoplexy of energy, wet, pathogenic heat, Radix Et Rhizoma Rhei again can activating blood and promoting diuresis.
The invention has the beneficial effects as follows: Chinese medicine preparation of the present invention has QI invigorating the moon and does not hinder wet, heat-clearing and toxic substances removing not hinder positive satisfactory to both parties effect, in the treatment nephropathy positive effect is arranged, and through clinical experiment, therapeutic effect is remarkable, the cure rate height.
Four, the specific embodiment:
Embodiment 1: be made up of the following raw materials of effective components of making: 15 parts of Cordyceps, 20 parts of the Radixs Astragali, 5 parts in Radix Glycyrrhizae, 5 parts of Radix Et Rhizoma Rhei, 8 parts of Fructus Schisandrae Chinensis, 12 parts of Sargassums, 20 parts in the Radix Rehmanniae, 20 parts in Radix Rehmanniae Preparata, 15 parts of 5 parts of Rhizoma Chuanxiongs, 5 parts in Moschus, 5 parts of Calculus Boviss, 15 parts of Radix Polygoni Multiflori, 20 parts of Rhizoma dioscoreaes, 15 parts of Radix Panacis Quinquefoliis and Radix Angelicae Sinensis.Ground 80 mesh sieves into powder, it is standby that stirring shakes up sealing.
Embodiment 2: be made up of the following raw materials of effective components of making: 25 parts of Cordyceps, 30 parts of the Radixs Astragali, 12 parts in Radix Glycyrrhizae, 12 parts of Radix Et Rhizoma Rhei, 12 parts of Fructus Schisandrae Chinensis, 18 parts of Sargassums, 28 parts in the Radix Rehmanniae, 28 parts in Radix Rehmanniae Preparata, 25 parts of 12 parts of Rhizoma Chuanxiongs, 8 parts in Moschus, 12 parts of Calculus Boviss, 25 parts of Radix Polygoni Multiflori, 35 parts of Rhizoma dioscoreaes, 25 parts of Radix Panacis Quinquefoliis and Radix Angelicae Sinensis.Ground 80 mesh sieves into powder, it is standby that stirring shakes up sealing.
Embodiment 3: be made up of the following raw materials of effective components of making: 20 parts of Cordyceps, 25 parts of the Radixs Astragali, 9 parts in Radix Glycyrrhizae, 9 parts of Radix Et Rhizoma Rhei, 10 parts of Fructus Schisandrae Chinensis, 16 parts of Sargassums, 25 parts in the Radix Rehmanniae, 25 parts in Radix Rehmanniae Preparata, 20 parts of 10 parts of Rhizoma Chuanxiongs, 6 parts in Moschus, 10 parts of Calculus Boviss, 20 parts of Radix Polygoni Multiflori, 30 parts of Rhizoma dioscoreaes, 20 parts of Radix Panacis Quinquefoliis and Radix Angelicae Sinensis.Ground 80 mesh sieves into powder, it is standby that stirring shakes up sealing.
The using method of this medicine is: each 3 grams, every day three times, three months is a course of treatment, is applicable to treatment chronic nephritis, the nephrotic syndrome, and excellent curative is arranged.
Therapeutic effect (clinical trial 100 examples of the present invention, its result is as follows)
(1) criterion of therapeutical effect
Recovery from illness: symptom and sign disappears, and lab testing is normal, does not recur behind the hormone of stopping using;
Produce effects: symptom and sign disappears substantially, and lab testing significantly improves, and recurrence is than the lighter after the drug withdrawal;
Invalid: treating did not have the improver with clinical symptoms and laboratory examination in three months.
(2) result: 66 examples of fully recovering (accounting for 66%), produce effects 29 examples (accounting for 29%), invalid 5 examples (5%), cure rate reaches 66%, and total effective rate reaches 95%.
Model case
Xu xx, the woman, 28 years old, edema 2 years, oliguria, weak 2 months were admitted to hospital on November 20th, 2005, come before the institute successively at certain county hospital with nephrotic syndrome hospitalization, curative effect is not good enough, questions closely medical history, and the each state of an illness of patient is all relevant with the oral decrement of prednisone repeatedly, when reducing to every day during a slice left and right sides, the state of an illness often increases the weight of suddenly.
Have a medical check-up: puffiness of face, the eyes blepharoptosis, palpebral fissure narrows down, two lower limb are pitting edema, cardiopulmonary (-), urine protein (+++), erythrocyte (+++), granular cast a little, the solid liquor-saturated 10.6mmol/L. of blood plasma gallbladder
Diagnosis: the nephrotic syndrome, use medicine of the present invention, each 2 grams are withdrawn from after January every day three times, and hormone dosage decrescence, further consultation after three months, each disease all disappears, and the urine chemical examination is normal, advises continuous clothes three months, follows up a case by regular visits to not recur in 2 years.
Open xx, man, 58 years old.First visit on May 10 in 2005: weak, the nauseating prescription on individual diagnosis in certain hospital.Look into: blood Cr531 μ mol/L, BUN20.93mmol/L, CO2-CP11mmol/L examines and is " chronic renal failure ", hospitalization 3 months is produce effects not, after take February of the present invention after, check blood Cr358mmol/L, BUN24.82mmol/L continues clothes the present invention 1 month, and it is normal that Cr, BUN recover.Follow up a case by regular visits to so far stable disease.
Claims (2)
1. middle medicament for the treatment of nephropathy; it is characterized in that forming: Cordyceps 15-25 part, Radix Astragali 20-30 part, Radix Glycyrrhizae 5-12 part, Radix Et Rhizoma Rhei 5-12 part, Fructus Schisandrae Chinensis 8-12 part, Sargassum 12-18 part, Radix Rehmanniae 20-28 part, Radix Rehmanniae Preparata 20-28 part, Rhizoma Chuanxiong 5-12 part, Moschus 5-8 part, Calculus Bovis 5-12 part, Radix Polygoni Multiflori 15-25 part, Rhizoma dioscoreae 20-35 part, Radix Panacis Quinquefolii 15-25 part and Radix Angelicae Sinensis 15-25 part by the following raw materials of effective components of making.
2. the middle medicament of treatment nephropathy according to claim 1; it is characterized in that forming: 20 parts of Cordyceps, 25 parts of the Radixs Astragali, 9 parts in Radix Glycyrrhizae, 9 parts of Radix Et Rhizoma Rhei, 10 parts of Fructus Schisandrae Chinensis, 16 parts of Sargassums, 25 parts in the Radix Rehmanniae, 25 parts in Radix Rehmanniae Preparata, 20 parts of 10 parts of Rhizoma Chuanxiongs, 6 parts in Moschus, 10 parts of Calculus Boviss, 20 parts of Radix Polygoni Multiflori, 30 parts of Rhizoma dioscoreaes, 20 parts of Radix Panacis Quinquefoliis and Radix Angelicae Sinensis by the following raw materials of effective components of making.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101146621A CN101181466B (en) | 2007-11-27 | 2007-11-27 | Chinese traditional medicine for curing nephrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101146621A CN101181466B (en) | 2007-11-27 | 2007-11-27 | Chinese traditional medicine for curing nephrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101181466A CN101181466A (en) | 2008-05-21 |
| CN101181466B true CN101181466B (en) | 2010-06-09 |
Family
ID=39446978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101146621A Expired - Fee Related CN101181466B (en) | 2007-11-27 | 2007-11-27 | Chinese traditional medicine for curing nephrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101181466B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105168970A (en) * | 2014-06-04 | 2015-12-23 | 王欣茹 | Traditional Chinese medicinal preparation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1876089A (en) * | 2005-06-09 | 2006-12-13 | 张友生 | A pharmaceutical composition for treating kidney-qi deficiency syndrome and preparation method thereof |
| CN1935225A (en) * | 2005-09-23 | 2007-03-28 | 田继山 | Chinese medicine for treating renal failure and urotoxia, and its preparing method |
-
2007
- 2007-11-27 CN CN2007101146621A patent/CN101181466B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1876089A (en) * | 2005-06-09 | 2006-12-13 | 张友生 | A pharmaceutical composition for treating kidney-qi deficiency syndrome and preparation method thereof |
| CN1935225A (en) * | 2005-09-23 | 2007-03-28 | 田继山 | Chinese medicine for treating renal failure and urotoxia, and its preparing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101181466A (en) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN101130030A (en) | Medicine composition for treating nephropathy and uses of the same | |
| CN102488743B (en) | Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation | |
| CN102247586A (en) | Medicine for treating asthma and preparation method thereof | |
| CN102579755A (en) | Chinese medicinal formula for treating chronic renal failure | |
| CN101612329A (en) | Traditional Chinese medicine for treating glomerulonephritis | |
| CN101791385B (en) | Medicine for treating psoriasis | |
| CN106389757A (en) | Diabetic nephropathy treating pharmaceutical composition, preparation method and uses thereof | |
| CN102091306A (en) | Medicine for treating senile chronic colitis | |
| CN101181466B (en) | Chinese traditional medicine for curing nephrosis | |
| CN100490879C (en) | Ready-made Chinese medicine jelly-pills for treating hypertension and its preparation method | |
| CN102008645B (en) | Traditional Chinese medicine capsule for treating jaundice hepatitis | |
| CN101966291A (en) | Chinese herbal medicine syrup for treating acute and chronic bronchitis, pulmonary tuberculosis and pulmonary emphysema | |
| CN101912596A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
| CN1183931C (en) | Medicine for treating kidney disease | |
| CN102284009B (en) | Chinese medicinal herb syrup for treating acute and chronic bronchitis, tuberculosis and emphysema | |
| CN101716311B (en) | Traditional Chinese medical pill for treating hepatitis B | |
| CN101130003A (en) | Traditional Chinese medicine for treating acute cholecystitis | |
| CN102266533A (en) | Liver softening and regenerating granules and preparation method thereof | |
| CN103961663A (en) | Chinese herbal medicine for treating hyperosteogeny | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN102379994A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN101766749A (en) | Chinese patent medicine for treating chronic rhinitis and nasosinusitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU YONGXIANG LIU YUNFENG Owner name: BAO JIANZHOU Free format text: FORMER OWNER: LIU YINGYAN Effective date: 20100326 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Bao Jianzhou Inventor after: Liu Yongxiang Inventor after: Liu Yunfeng Inventor after: Yang Kerang Inventor after: Zhang Mei Inventor before: Liu Yingyan |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 257200 HOSPITAL OF TRADITIONAL CHINESE MEDICINE, NO.4, HAINING ROAD, HEKOU DISTRICT, DONGYING CITY, SHANDONG PROVINCE TO: 257335 DONGYING CITY 2ND PEOPLE S HOSPITAL NO.28, CHANGCHUN ROAD, DAWANG TOWN, GUANGRAO COUNTY, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIU YINGYAN TO: BAO JIANZHOU LIU YONGXIANG LIU YUNFENG YANG KERANG ZHANG MEI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20100326 Address after: 257335 Shandong province Guangrao County, Zhen Chang Chun Lu Second People's Hospital of Dongying City, No. 28 Applicant after: Bao Jianzhou Applicant after: Liu Yongxiang Applicant after: Liu Yunfeng Address before: 257200 4 Hospital of traditional Chinese medicine, Haining Road, Hekou District, Shandong, Dongying Applicant before: Liu Yingyan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100609 Termination date: 20101127 |